1. Home
  2. TSHA vs TH Comparison

TSHA vs TH Comparison

Compare TSHA & TH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$4.38

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Target Hospitality Corp.

TH

Target Hospitality Corp.

SELL

Current Price

$18.97

Market Cap

1.8B

ML Signal

SELL

Company Overview

Basic Information
Metric
TSHA
TH
Founded
2019
1978
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
TSHA
TH
Price
$4.38
$18.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
5
Target Price
$13.00
★ $25.20
AVG Volume (30 Days)
★ 3.2M
2.1M
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 5.56
N/A
EPS
N/A
★ N/A
Revenue
$9,773,000.00
★ $320,635,000.00
Revenue This Year
N/A
$36.96
Revenue Next Year
$1,023.00
$71.08
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 17.28
N/A
52 Week Low
$3.69
$5.97
52 Week High
$7.30
$21.76

Technical Indicators

Market Signals
Indicator
TSHA
TH
Relative Strength Index (RSI) 29.00 46.78
Support Level $4.37 $18.43
Resistance Level $4.72 $20.66
Average True Range (ATR) 0.26 0.87
MACD -0.02 -0.21
Stochastic Oscillator 1.38 15.66

Price Performance

Historical Comparison
TSHA
TH

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.

About TH Target Hospitality Corp.

Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services, including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. The company has three reportable segments: HFS - South, which provides specialty rental and hospitality services to the natural resources and development industry; WHS, which provides construction and hospitality solutions for critical mineral and data center projects; and Government, which provides specialty rental and hospitality services under government contracts.

Share on Social Networks: